CMPMedica to supply iSOFT with drug data products

Health information company CMPMedica has signed a contract to supply iSOFT with evidence-based drug information, in a move iSOFT says will make patient safety a priority.

The global contract, which was signed in December, means CMPMedica will supply the information iSOFT needs to operate its decision support tools.

iSOFT chief medical officer Michael Dahlweid said the agreement will enable the company to provide its customers with up-to-date information, as well as improve patient safety.

"This new service will strengthen the quality of the drug content available within iSOFT products giving our customers ready access to the very latest drug and allergy information," he said.

"This will ensure prescribing clinicians have up-to-date and fully integrated drug information to enhance patient treatment and safety."

"This makes patient safety the priority in a world of increasing drug complexity."

CMPMedica chief executive officer Henry Elkington said the company has a strong relationship with iSOFT, having supplied them with medicine information systems in the past.

"The award of this contract demonstrates that we are addressing the needs of one of the most dynamic multi-national healthcare solution providers," he said.

He said CMPMedica works to combine internationally referenced alert tools with local product information, delivered to its clients' IT partners through a common interface.

"By providing trusted local data with best-in-class decision support tools we are enabling solutions that will be recognised and welcomed by clinicians," Mr Elkington said.

"By delivering data through a common interface we can speed up and simplify deployment for the solution provider."

Dr Dahlweid said the agreement would also allow the company improved and real-time access to CMPMedica's knowledge bases.

"When interacting with iSOFT products, these decision support tools will provide the capacity to alert clinicians to interactions between medicines, food, health conditions and patient allergies and more," he said.

Posted in Australian eHealth

You need to log in to post comments. If you don't have a Pulse+IT website account, click here to subscribe.

Sign up for Pulse+IT eNewsletters

Sign up for Pulse+IT website access

For more information, click here.

Copyright © 2021 Pulse+IT Communications Pty Ltd
No content published on this website can be reproduced by any person for any reason without the prior written permission of the publisher.
Supported by Social Media Agency | pepperit